1. 简体中文
  2. English
语言入口:
科研成果

文章发表

发布者::GMP   发布时间: :2012-02-12 16:21 浏览次数: :

1、  Juanjuan Zhu, Ziye Rong, Bing Jiang and Jing Liu. (2008) Characterization and Analysis of the Aggregation of a Single-chain Chimeric Anti- ErbB2 Antibody.Chinese Journal of Biotechnology, 25(11),1918-1923

2、  Fu Lu, Huang Hui,Chen Shuyang,Chu Bo, Liu Jing.2009Mass-scale Purification and Quality of a Single-chain Chemeric Anti-ErbB2 Antibody. China Biotechnology. 29(7):68-73

3、  S. Hu, Z. Zhu, L. Li, L. Chang, W.F. L., L. Cheng, M. Teng, J. Liu. Fine epitope mapping and structural analysis of an anti-ErbB2 antibody A21: Molecular basis for anti-tumor mechanism. Accepted by Proteins, 2008; 70:938949.

4、  Y. Liu, H. Zhou, J. Zhu, Y. Gao, L. Niu, J. Liu and M. Teng. Crystallization and preliminary crystallographic studies of the single-chain variable fragment of antibody chA21 in complex with an N-terminal fragment of ErbB2. Acta Cryst. (2009). F65, 692-694 .

5、  朱娟娟,赵斌,刘兢;抗ErbB2嵌合抗体chA21SKBR3细胞的增殖抑制以及对PI3K/AktErk1/2信号转导途径的影响。中国药理学通报, 2009 ,25:421-424

6、  Guodong Shen,Hui Huang,Anli Zhang,Ting Zhao ,Siyi Hu, Liansheng Cheng,Jing Liu,Weihua Xiao,Bin Ling, Qiang Wu,Lihua Song,Wei Wei. In vivo activity of novel anti-ErbB2 antibody chA21 alone and with Paclitaxel or Trastuzumab in breast and ovarian cancer xenograft models. Cancer Immunol Immunother. Cancer Immunol Immunother (2011) 60:339–348

7、  人干扰素α2bIgG Fc片段融合蛋白显著延长体内半衰期[J]. , ,肖卫华.生物工程学报,2008,24(1):53~62

8、  Ma ML,Cheng YY, Xu ZH, Xu P, Qu HO, Fang YJ, Xu TW, Wen LP. Evaluation of Polyamidoamine (PAMAM) Dendrimers as Drug Carriers of Anti-bacterial Drugs Using Sulfamethoxazole (SMZ) as a Model Drug. European Journal of Medicinal Chemistry 4293-98 (2007)